| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2877677 | The Annals of Thoracic Surgery | 2011 | 6 Pages |
Abstract
The 5-year survival rate of patients with pathologic stage IA NSCLC and IPF is 54.2%. IPF has independent, adverse effects on survival of pathologic stage IA NSCLC patients treated with pulmonary resection.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Yuichi MD, Yasuyuki MD, Nobumasa MD, PhD, Tomohiko MD, PhD, Katsumi MD, PhD, Yoshinori MD, PhD, Eishin MD, PhD,